Phoenix Canada Oil, an oil and gas exploration company, completed the acquisition of ZYUS Life Sciences, a phyto-therapeutics company, for $160m. “The closing of this transaction is the beginning of a transformational moment in ZYUS’ history and provides us with the resources to further advance our operations and accelerate our clinical research activities. This achievement brings us one step closer to providing patients with an approved pharmaceutical drug as an alternative to current pain management therapies. Our mission is to improve the quality of life and well-being for the billions of people worldwide who suffer from chronic pain,” Brent Zettl, ZYUS President and CEO.